LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 59

Search options

  1. Article ; Online: Novel Approach for Screening and Early Diagnosis of Ataxia-Telangiectasia.

    Shamriz, Oded

    The journal of allergy and clinical immunology. In practice

    2021  Volume 9, Issue 2, Page(s) 733–734

    MeSH term(s) Ataxia Telangiectasia/diagnosis ; DNA Repair ; Early Diagnosis ; Humans ; Infant ; Infant, Newborn ; Neonatal Screening ; Severe Combined Immunodeficiency
    Language English
    Publishing date 2021-02-08
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 2843237-X
    ISSN 2213-2201 ; 2213-2198
    ISSN (online) 2213-2201
    ISSN 2213-2198
    DOI 10.1016/j.jaip.2020.08.040
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Editorial: Dermatologic manifestations of primary immune deficiency disorders in children.

    Shamriz, Oded / Chandrakasan, Shanmuganathan

    Frontiers in pediatrics

    2023  Volume 11, Page(s) 1182474

    Language English
    Publishing date 2023-03-31
    Publishing country Switzerland
    Document type Editorial
    ZDB-ID 2711999-3
    ISSN 2296-2360
    ISSN 2296-2360
    DOI 10.3389/fped.2023.1182474
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Reply to Wang et al.

    Nemet, Shay / Sergienko, Ruslan / Shamriz, Oded

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

    2024  Volume 35, Issue 4, Page(s) e14123

    Language English
    Publishing date 2024-04-04
    Publishing country England
    Document type Letter
    ZDB-ID 1057059-7
    ISSN 1399-3038 ; 0905-6157 ; 0906-5784
    ISSN (online) 1399-3038
    ISSN 0905-6157 ; 0906-5784
    DOI 10.1111/pai.14123
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Probiotics and autoimmunity: Current evidence.

    Shamriz, Oded

    Autoimmunity reviews

    2018  Volume 17, Issue 11, Page(s) 1150–1151

    Language English
    Publishing date 2018-09-10
    Publishing country Netherlands
    Document type Letter
    ZDB-ID 2144145-5
    ISSN 1873-0183 ; 1568-9972
    ISSN (online) 1873-0183
    ISSN 1568-9972
    DOI 10.1016/j.autrev.2018.06.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Polyautoimmunity: Risk factors for a unique clinical entity.

    Shamriz, Oded

    Autoimmunity reviews

    2018  Volume 17, Issue 8, Page(s) 842–843

    Language English
    Publishing date 2018-06-06
    Publishing country Netherlands
    Document type Letter
    ZDB-ID 2144145-5
    ISSN 1873-0183 ; 1568-9972
    ISSN (online) 1873-0183
    ISSN 1568-9972
    DOI 10.1016/j.autrev.2018.03.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Editorial: Rare immune-mediated diseases- novel insights into underlying mechanisms and therapeutic approaches.

    Shamriz, Oded / Adini, Irit / Tal, Yuval

    Frontiers in immunology

    2023  Volume 14, Page(s) 1273062

    Language English
    Publishing date 2023-08-14
    Publishing country Switzerland
    Document type Editorial
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2023.1273062
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Genetics of Immune Dysregulation and Cancer Predisposition: Two Sides of the Same Coin.

    Matza Porges, Sigal / Shamriz, Oded

    Clinical and experimental immunology

    2022  Volume 210, Issue 2, Page(s) 114–127

    Abstract: Approximately 10% of cancers have a hereditary predisposition. However, no genetic diagnosis is available in 60%-80% of familial cancers. In some of these families, immune dysregulation-mediated disease is frequent. The immune system plays a critical ... ...

    Abstract Approximately 10% of cancers have a hereditary predisposition. However, no genetic diagnosis is available in 60%-80% of familial cancers. In some of these families, immune dysregulation-mediated disease is frequent. The immune system plays a critical role in identifying and eliminating tumors; thus, dysregulation of the immune system can increase the risk of developing cancer. This review focuses on some of the genes involved in immune dysregulation the promote the risk for cancer. Genetic counseling for patients with cancer currently focuses on known genes that raise the risk of cancer. In missing hereditary familial cases, the history family of immune dysregulation should be recorded, and genes related to the immune system should be analyzed in relevant families. On the other hand, patients with immune disorders diagnosed with a pathogenic mutation in an immune regulatory gene may have an increased risk of cancer. Therefore, those patients need to be under surveillance for cancer. Gene panel and exome sequencing are currently standard methods for genetic diagnosis, providing an excellent opportunity to jointly test cancer and immune genes.
    MeSH term(s) Humans ; Genetic Predisposition to Disease ; Exome Sequencing ; Neoplasms/genetics ; Mutation/genetics
    Language English
    Publishing date 2022-09-27
    Publishing country England
    Document type Review ; Journal Article
    ZDB-ID 218531-3
    ISSN 1365-2249 ; 0009-9104 ; 0964-2536
    ISSN (online) 1365-2249
    ISSN 0009-9104 ; 0964-2536
    DOI 10.1093/cei/uxac089
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Autoimmune Diseases Induced or Exacerbated by COVID-19: A Single Center Experience.

    Ishay, Yuval / Kenig, Ariel / Rubin, Limor / Shamriz, Oded / Kharouf, Fadi

    Autoimmune diseases

    2022  Volume 2022, Page(s) 9171284

    Abstract: The association between infectious diseases and autoimmunity has long been reported. Specifically, during the coronavirus disease 2019 (COVID-19) pandemic, this relation was further emphasized. The interplay between the two disease processes remains ... ...

    Abstract The association between infectious diseases and autoimmunity has long been reported. Specifically, during the coronavirus disease 2019 (COVID-19) pandemic, this relation was further emphasized. The interplay between the two disease processes remains interesting, yet incompletely defined. Herein, we report a case series of six patients presenting with autoimmune phenomena first developed or exacerbated following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We describe the disease course and discuss the possible mechanisms underlying the association between autoimmunity and COVID-19.
    Language English
    Publishing date 2022-09-06
    Publishing country United States
    Document type Journal Article
    ISSN 2090-0422
    ISSN 2090-0422
    DOI 10.1155/2022/9171284
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Increased rates of idiopathic inflammatory myopathies during the COVID-19 pandemic: a single-centre experience.

    Kharouf, Fadi / Kenig, Ariel / Bohbot, Emilie / Rubin, Limor / Peleg, Hagit / Shamriz, Oded

    Clinical and experimental rheumatology

    2023  Volume 41, Issue 2, Page(s) 316–321

    Abstract: Objectives: Higher-level evidence is required to discern whether the incidence of idiopathic inflammatory myopathies (IIM) has increased during the COVID-19 pandemic and whether the disease pattern and course have changed. We aimed to analyse patients ... ...

    Abstract Objectives: Higher-level evidence is required to discern whether the incidence of idiopathic inflammatory myopathies (IIM) has increased during the COVID-19 pandemic and whether the disease pattern and course have changed. We aimed to analyse patients who were diagnosed with IIM at our tertiary care centre during the pandemic and compare them with IIM patients diagnosed before COVID-19.
    Methods: We retrospectively analysed the medical records of adult patients (>18 years) who were diagnosed with IIM during COVID-19 versus a control group of patients diagnosed before the outbreak. Included were patients whose diagnosis was made at the Department of Medicine and Rheumatology Unit of Hadassah Medical Center, Jerusalem, Israel. We also conducted a comprehensive review of the literature regarding SARS-CoV-2 infection and vaccine-induced IIM.
    Results: Our study yielded 18 and 16 diagnosed IIM patients over periods of 27 and 56 months in the COVID-19 and pre-pandemic cohorts, respectively. These constitute incidence rates of 0.66 and 0.28 patients/month, respectively, marking an increased rate in the COVID-19 group. Unique features were noted in IIM patients who were diagnosed during the pandemic. This includes male predominance (M:F ratio of 12:6), higher hospitalisation rate (0.77 vs. 0.43 admitted/total patients) and increased number of patients with CPK >10,000 U/L (3 vs. 1 patient). Despite the more severe presentation and course in the pandemic group, survival was comparable between the groups.
    Conclusions: The incidence of IIM increased during the COVID-19 pandemic. These patients display unique features and a more severe presentation. Fortunately, the prognosis remains unchanged.
    MeSH term(s) Adult ; Humans ; Male ; Female ; Pandemics ; Retrospective Studies ; COVID-19 ; SARS-CoV-2 ; Myositis/diagnosis
    Language English
    Publishing date 2023-02-23
    Publishing country Italy
    Document type Review ; Journal Article
    ZDB-ID 605886-3
    ISSN 1593-098X ; 0392-856X
    ISSN (online) 1593-098X
    ISSN 0392-856X
    DOI 10.55563/clinexprheumatol/970881
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Successful ligelizumab treatment of severe refractory solar urticaria.

    Hershkovitz, Yoav / Khanimov, Israel / Rubin, Limor / Dranitzki, Zvika / Talmon, Aviv / Ribak, Yaarit / Shamriz, Oded / Levi, Asi / Tal, Yuval

    The journal of allergy and clinical immunology. In practice

    2023  Volume 11, Issue 8, Page(s) 2576–2577

    MeSH term(s) Humans ; Urticaria, Solar ; Antibodies, Monoclonal, Humanized/therapeutic use ; Urticaria/drug therapy ; Omalizumab/therapeutic use
    Chemical Substances ligelizumab (L8LE0L691T) ; Antibodies, Monoclonal, Humanized ; Omalizumab (2P471X1Z11)
    Language English
    Publishing date 2023-02-15
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2843237-X
    ISSN 2213-2201 ; 2213-2198
    ISSN (online) 2213-2201
    ISSN 2213-2198
    DOI 10.1016/j.jaip.2023.01.052
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top